IGNE — Igene Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro Cap

Annual balance sheet for Igene Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2005 December 31st	2006 December 31st	2007 December 31st	2008 December 31st	2009 December 31st
Period Length:	—	—	—	—	—
Source:	10KSB	10KSB/A	10KSB	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.12	0.022	1.03	1.49	1.3
Net Total Accounts Receivable
Net Total Receivables	0.016	—	2.72	1.05	2.32
Total Inventory
Prepaid Expenses
Total Current Assets	0.157	0.036	11.8	4.96	3.66
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.051	0.034	0.713	0.832	0.853
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	0.233	0.075	13.1	6.07	4.76
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.816	0.962	7.9	2.85	1.56
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.4	12.3	27.2	8.51	7.26
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-15.1	-12.3	-14.1	-2.44	-2.5
Total Liabilities & Shareholders' Equity	0.23	0.074	13.1	6.07	4.76
Total Common Shares Outstanding
Total Preferred Shares Outstanding